newest glp 1 drug GLP-1 Agonists: A Comprehensive Overview How a Desert Lizard Helped
Description
Parhizgar, Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (FAERS)Disproportionality Study, J
Con: Lixisenatide (daily) is more than twice as likely to cause nausea (25%) than weekly exenatide (Bydureon)
Karakasis et al
95% CI, 0.780.91), and opioid use disorders (HR 0.87
Individual body chemistry determines tolerance more than the medication choice
